HDCRT Plus Pembrolizumab in Advanced Malignancies

Clinical trial NCT02987166 · COMPLETED

Trial details

NCT number

NCT02987166

Sponsor

James Larner, MD

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-03-21

Primary completion

2020-01-13

Enrollment

21

View on ClinicalTrials.gov